Abstract
MUC1 expression in cholangiocarcinoma is considered to be correlated with patient survival. We report a case of mass-forming type intrahepatic cholangiocarcinoma (ICC) with direct infiltration of the transverse colon and sequential brain metastasis. The patient was treated by curative right hepatectomy with right hemicolectomy followed by resection of the brain metastasis; there has been no evidence of recurrence in the 7 years since the hepatic resection. Thus, surgical resection may improve the prognosis of ICC involving the adjacent organs, even with brain metastasis. Immunohistochemical staining was performed for MUC1, MUC2, and MUC5AC. Although MUC1 expression was found in the liver tumor and metastatic brain tumor, the correlation between MUC1 expression and the prognosis of this patient was unclear. To clarify the correlation between immunohistochemical characteristics and prognosis, further studies on a greater number of cases of long-term survival of mass-forming type ICC are needed.
Similar content being viewed by others
References
The liver study group of Japan. Primary liver cancer in Japan. Sixth report. Cancer 1987;60:1400–1411.
Hasegawa K, Kokudo N. Surgical treatment of hepatocellular carcinoma. Surg Today 2009;39:833–843.
Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005;366:1303–1314.
Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg 2008;32:2675–2680.
Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, et al. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg 2009;33:1247–1254.
Yedibela S, Demir R, Zhang W, Meyer T, Hohenberger W, Schonleben F. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients. Ann Surg Oncol 2009;16:404–412.
Inoue K, Makuuchi M, Takayama T, Torzilli G, Yamamoto J, Shimada K, et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 2000;127:498–505.
Shimamura K, Kurosaki I, Sato D, Takano K, Yokoyama N, Sato Y, et al. intrahepatic cholangiocarcinoma arising 34 years after excision of a type IV-A congenital choledochal cyst: report of a case. Surg Today 2009;39:247–251.
Kaminishi T, Hirohashi K, Yamasaki O, Kubo S, Yamamoto T, Syuto T, et al. Analysis of intrahepatic cholangiocarcinoma combined resection with directly involvement other adjacent organs (in Japanese). Jpn J Gastroenterol Surg 2002;35:922.
Hui AM, Kawasaki S, Hashikura Y, Ishida K, Miyazawa K, Makuuchi M. Long-term survival after surgery for advanced intrahepatic cholangiocarcinoma; a case report. Hepatogastroenterology 1997;44:813–816.
Pandey D, Lee KH, Wong SY, Tan KC. Adrenal metastasis from intrahepatic cholangiocarcinoma. Liver Int 2007;27:1016.
Gudesblatt MS, Sencer W, Sacher M, Lanzieri CF, Song SK. Cholangiocarcinoma presenting as a cerebellar metastasis: case report and review of the literature. J Comput Tomogr 1984;8:191–195.
Park SY, Roh SJ, Kim YN, Kim SZ, Park HS, Jang KY, Chung MJ, et al. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact. Oncol Rep 2009;22:649–657.
Matsumura N, Yamamoto M, Aruga A, Takasaki K, Nakano M. Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma. Cancer 2002;94:1770–1776.
Boonla C, Spira B, Thuwajit P, Cha-On U, Puapairoj A, Miwa M, Wongkham S. MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma. World J Gastroenterol 2005;11:4939–4946.
Boonla C, Wongkham S, Sheehan JK, Wongkham C, Bhudhisawasdi V, Tepsiri N, et al. Prognostic value of serum MUC5AC mucin in patients with cholangiocarcinoma. Cancer 2003;98:1438–1443.
Yonezawa S, Sueyoshi K, Nomoto M, Kitamura H, Nagata K, Arimura Y, et al. MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients. Hum Pathol 1997;28:344–3452.
Choi HJ, Cho BC, Sohn JH, Shin SJ, Kim SH, Kim JH, et al. Brain metastases from hepatocellular carcinoma: prognostic factors and outcome. J Neurooncol 2009;91:307–313.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mimatsu, K., Oida, T., Kawasaki, A. et al. Long-term survival after resection of mass-forming type intrahepatic cholangiocarcinoma directly infiltrating the transverse colon and sequential brain metastasis: Report of a case. Surg Today 41, 1410–1413 (2011). https://doi.org/10.1007/s00595-010-4500-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-010-4500-0